Shares of Monsanto (NYSE:MON) have been given a consensus rating of “Hold” by the fourteen brokerages that are presently covering the stock, MarketBeat Ratings reports. Eleven analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $125.84.

A number of analysts have recently issued reports on the company. Deutsche Bank reaffirmed a “buy” rating on shares of Monsanto in a research report on Tuesday. Royal Bank of Canada reaffirmed a “hold” rating and issued a $128.00 price objective on shares of Monsanto in a research report on Wednesday, November 15th. Wells Fargo & Co raised their price objective on Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a research report on Tuesday, October 10th. Macquarie cut Monsanto from an “outperform” rating to a “neutral” rating in a research report on Wednesday, October 4th. Finally, Barclays reaffirmed an “equal weight” rating and issued a $124.00 price objective (up from $120.00) on shares of Monsanto in a research report on Thursday, October 5th.

In related news, CFO Pierre Courduroux sold 4,320 shares of Monsanto stock in a transaction that occurred on Thursday, October 19th. The stock was sold at an average price of $122.00, for a total transaction of $527,040.00. Following the completion of the sale, the chief financial officer now directly owns 48,388 shares of the company’s stock, valued at approximately $5,903,336. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Steven Mizell sold 8,100 shares of Monsanto stock in a transaction that occurred on Tuesday, January 9th. The stock was sold at an average price of $119.35, for a total value of $966,735.00. Following the sale, the executive vice president now directly owns 56,743 shares of the company’s stock, valued at $6,772,277.05. The disclosure for this sale can be found here. Company insiders own 0.70% of the company’s stock.

Institutional investors have recently bought and sold shares of the business. Bruderman Asset Management LLC bought a new position in Monsanto during the 2nd quarter worth $116,000. Tower Research Capital LLC TRC increased its stake in Monsanto by 230.1% during the 2nd quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock worth $128,000 after acquiring an additional 750 shares during the period. Americafirst Capital Management LLC bought a new position in Monsanto during the 3rd quarter worth $148,000. Fieldpoint Private Securities LLC increased its stake in Monsanto by 100.6% during the 2nd quarter. Fieldpoint Private Securities LLC now owns 1,575 shares of the basic materials company’s stock worth $186,000 after acquiring an additional 790 shares during the period. Finally, Loews Corp bought a new position in Monsanto during the 2nd quarter worth $202,000. Hedge funds and other institutional investors own 75.37% of the company’s stock.

Monsanto (MON) traded up $0.29 on Tuesday, hitting $120.00. The stock had a trading volume of 553,640 shares, compared to its average volume of 3,050,000. Monsanto has a 52 week low of $106.97 and a 52 week high of $122.79. The firm has a market capitalization of $52,820.00, a PE ratio of 22.18, a price-to-earnings-growth ratio of 1.71 and a beta of 1.04. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.79 and a current ratio of 1.28.

Monsanto (NYSE:MON) last released its quarterly earnings data on Thursday, January 4th. The basic materials company reported $0.41 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.01). Monsanto had a net margin of 16.38% and a return on equity of 40.13%. The business had revenue of $2.66 billion during the quarter, compared to analyst estimates of $2.77 billion. During the same period in the previous year, the business earned $0.21 earnings per share. The business’s quarterly revenue was up .3% on a year-over-year basis. analysts forecast that Monsanto will post 5.76 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, January 5th will be issued a dividend of $0.54 per share. The ex-dividend date of this dividend is Thursday, January 4th. This represents a $2.16 annualized dividend and a yield of 1.80%. Monsanto’s payout ratio is currently 39.93%.

TRADEMARK VIOLATION NOTICE: “Monsanto (MON) Given Consensus Recommendation of “Hold” by Brokerages” was published by American Banking News and is the property of of American Banking News. If you are reading this piece on another domain, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The legal version of this piece can be read at https://www.americanbankingnews.com/2018/01/16/monsanto-mon-given-consensus-recommendation-of-hold-by-brokerages.html.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Analyst Recommendations for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.